Cleaned up conformance level for ingredients in the substances ontology after review of ISO 11615; added conformance levels and regularized the modeling of age as a population characteristic, with conformance details in the medicinal products ontology
Additional refinement of annotations related to medicinal
products, including elements related to administrable dose forms and authorized medicinal products
Added annotations for a number of additional concepts and cleaned up the model in a few cases, such as for batch, clinical trial, and gender related elements
Added notes regarding controlled vocabularies not specified in the IDMP standard and extensions to the definition of interaction
Extended definitions of medicinal product header, manufacturing authorization to cover pharma company usage examples
Description: